drugset / Trial / NCT00556140
The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to assess the safety and effectiveness of the combination of aripiprazole (Abilify) and selective serotonin reuptake inhibitors (SSRIs) in subjects with psychotic major depression.
Timeline
- Start
- 2003-06
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 10 mg | — |